[HTML][HTML] Biomarkers for prostate cancer: prostate-specific antigen and beyond
MJ Duffy - Clinical Chemistry and Laboratory Medicine (CCLM), 2020 - degruyter.com
In recent years, several new biomarkers supplementing the role of prostate-specific antigen
(PSA) have become available for men with prostate cancer. Although widely used in an ad …
(PSA) have become available for men with prostate cancer. Although widely used in an ad …
Prostate cancer screening and treatment: where have we come from and where are we going?
PC Albertsen - BJU international, 2020 - Wiley Online Library
Objective To evaluate the current prostate cancer screening and treatment paradigm in light
of recently published long‐term results of major screening and treatment trials. Methods …
of recently published long‐term results of major screening and treatment trials. Methods …
Patient-reported outcomes through 5 years for active surveillance, surgery, brachytherapy, or external beam radiation with or without androgen deprivation therapy for …
Importance Understanding adverse effects of contemporary treatment approaches for men
with favorable-risk and unfavorable-risk localized prostate cancer could inform treatment …
with favorable-risk and unfavorable-risk localized prostate cancer could inform treatment …
Radical prostatectomy or observation for clinically localized prostate cancer: extended follow-up of the Prostate Cancer Intervention Versus Observation Trial (PIVOT)
Background Very long-term mortality in men with early prostate cancer treated with surgery
versus observation is uncertain. Objective To determine long-term effects of surgery versus …
versus observation is uncertain. Objective To determine long-term effects of surgery versus …
[HTML][HTML] 1.5 T MR-guided and daily adapted SBRT for prostate cancer: feasibility, preliminary clinical tolerability, quality of life and patient-reported outcomes during …
F Alongi, M Rigo, V Figlia, F Cuccia, N Giaj-Levra… - Radiation …, 2020 - Springer
Abstract Background Unity Elekta is a unique magnetic resonance (MR)-linac that
conjugates a 1.5 Tesla MR unit with a 7 MV flattening filter free accelerator. A prospective …
conjugates a 1.5 Tesla MR unit with a 7 MV flattening filter free accelerator. A prospective …
Standardized nomenclature and surveillance methodologies after focal therapy and partial gland ablation for localized prostate cancer: an international …
AH Lebastchi, AK George, TJ Polascik, J Coleman… - European urology, 2020 - Elsevier
Background Focal therapy (FT) and partial gland ablation (PGA) are quickly adopted by
urologists and radiologists as an option for the management of localized prostate cancer …
urologists and radiologists as an option for the management of localized prostate cancer …
[HTML][HTML] Ten-year mortality, disease progression, and treatment-related side effects in men with localised prostate cancer from the ProtecT randomised controlled trial …
Abstract Background The ProtecT trial reported intention-to-treat analysis of men with
localised prostate cancer (PCa) randomly allocated to active monitoring (AM), radical …
localised prostate cancer (PCa) randomly allocated to active monitoring (AM), radical …
Fifteen year quality of life outcomes in men with localised prostate cancer: population based Australian prospective study
Objective To assess treatment related changes in quality of life up to 15 years after
diagnosis of localised prostate cancer. Design Population based, prospective cohort study …
diagnosis of localised prostate cancer. Design Population based, prospective cohort study …
[HTML][HTML] Reconsidering the trade-offs of prostate cancer screening
After the widespread adoption of prostate-specific antigen (PSA) screening in the early
1990s, prostate cancer diagnoses increased rapidly while death rates halved over the …
1990s, prostate cancer diagnoses increased rapidly while death rates halved over the …
Patient-reported outcomes following treatment of localised prostate cancer and their association with regret about treatment choices
Background Well-documented reports of patients' experiences with different treatments are
important for helping localised prostate cancer (LPC) patients choose among the available …
important for helping localised prostate cancer (LPC) patients choose among the available …